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Abstract: Melioidosis is an emerging disease in the Americas. This paper reviews confirmed cases,
the presence of Burkholderia pseudomallei and the organization of national surveillance policies for
melioidosis in South America. Confirmed cases in humans have been reported from Ecuador,
Venezuela, Colombia, Brazil, and Peru. The bacterium has been isolated from the environment in
Brazil and Peru. The state of Ceará, northeastern region of Brazil, is the only place where specific
public strategies and policies for melioidosis have been developed. We also discuss the urgent need
for health authorities in South America to pay greater attention to this disease, which has the potential
to have a high impact on public health, and the importance of developing coordinated strategies
amongst countries in this region.
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1. Introduction
Melioidosis is an infectious disease caused by Burkholderia pseudomallei, an environmental
bacterium that is being detected with increasing frequency across the world but that has only attracted
attention in the Americas in the past few years. Limmathurotsakul et al., in a recent review, estimated
that some 165,000 cases of the disease occurred each year in tropical areas of the globe, accounting for
approximately 89,000 deaths [1]. In this study, a substantial part of South America, including northern,
north-eastern and mid-western regions of Brazil, northeastern Colombia and south-western Venezuela,
and parts of Peru, Guyana, Suriname, Paraguay, Bolivia and Argentina, was considered to represent a
suitable environment for the bacterium [1].
Melioidosis is known to occur in the American continent; however, the true distribution of the
disease is undetermined. In South America, northeastern Brazil is known to be a definite endemic
area [1] and, by 2015, it had accounted for 32 of the 48 (67%) published cases from the whole continent
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(Table 1) [2]. This study broadens the perspective on melioidosis in South America by reviewing
reported cases and exploring the organisation of public policies. Despite the relative paucity of
published cases, melioidosis undoubtedly deserves to be included in the lists of infectious diseases of
potential epidemiologic importance in the region.
Table 1. Published Cases of Melioidosis in South America.
Case Age Gender Year ofDiagnosis
Country of
Diagnosis
Country Where
Infection Was Most
Likely Acquired
Outcome References
1 30 M 1962 Ecuador Ecuador Died [3]
2 50 M 1995 Venezuela Venezuela Survived [4]
3 60 M 1998 Colombia Colombia Survived [5]
4 65 M 1998 Colombia Colombia Survived [5]
5 50 M 2000 Venezuela Venezuela Survived [4]
6 66 M 2003 Portugal Venezuela Survived [6]
7 10 F 2003 Colombia Colombia Died [5]
8 40 M 2003 Colombia Colombia Died [5]
9 15 M 2003 Brazil Brazil Died [7–10]
10 14 F 2003 Brazil Brazil Died [7–10]
11 10 M 2003 Brazil Brazil Died [7–10]
12 12 F 2003 Brazil Brazil Survived [7–10]
13 50 M 2003 Netherlands Brazil Died [11]
14 46 F 2004 Colombia Colombia Survived [5]
15 28 M 2005 Spain Colombia Survived [5]
16 52 M 2005 Colombia Colombia Survived [5]
17 17 F 2005 Brazil Brazil Survived [12]
18 30 M 2005 Brazil Brazil Died [2,13]
19 22 M 2008 Colombia Colombia Survived [14]
20 17 M 2008 Brazil Brazil Died [15]
21 69 M 2008 Brazil Brazil Died [16,17]
22 48 M 2009 Brazil Brazil Survived [17]
23 47 M 2010 Brazil Brazil Survived [17]
24 28 M 2010 Brazil Brazil Died [18]
25 29 M 2010 Brazil Brazil Died [2]
26 56 M 2010 Brazil Brazil Survived [2]
27 53 M 2011 Brazil Brazil Survived [2]
28 3 M 2011 Brazil Brazil Died [2]
29 56 M 2011 Brazil Brazil Died [2]
30 7 M 2011 Brazil Brazil Survived [2]
31 29 M 2011 Brazil Brazil Survived [2]
32 21 M 2012 Brazil Brazil Died [2]
33 82 F 2012 Brazil Brazil Died [2]
34 31 M 2012 Colombia Colombia Survived [5]
35 36 M 2013 Colombia Colombia Survived [19,20]
36 19 F 2016 Peru Peru Died [21]
37 68 M 2013 Brazil Brazil Died [2]
38 57 M 2014 Brazil Brazil Died [2]
39 42 M 2014 Brazil Brazil Survived [2]
40 57 M 2014 Brazil Brazil Survived [2]
41 50 M 2014 Brazil Brazil Died [2]
41 72 M 2014? Colombia Colombia Survived [22]
42 42 M 2015 Brazil Brazil Survived [2]
43 13 F 2015 Brazil Brazil Died [23]
44 64 M 2016 Brazil Brazil Survived [23]
45 58 M 2016 Brazil Brazil Died [23]
46 54 M 2016 Brazil Brazil Survived [23]
47 100 M 2017 Brazil Brazil Died [23]
48 4 F 2017 Brazil Brazil Survived [23]
2. Review of Published Melioidosis Cases and the Presence of B. pseudomallei
In 1962, in Ecuador, Biegeleisen reported the first case of melioidosis in South America [3]. Fifteen
years later, French researchers reported the isolation of B. pseudomallei from Brazilian and Peruvian
soil [24,25]. Since these early descriptions, only sporadic human cases of melioidosis had been reported
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in four countries by the 1990s: Venezuela, Colombia, Brazil and Peru (in order of first reporting)
(Figure 1) [2,13,21]. A genetic study, which included isolates from Ecuador, Venezuela and Brazil,
suggested that isolates of B. pseudomallei from Central and South America probably had an African
origin and were most likely imported between 1650 and 1850, as a result of colonization and the slave
trade [26].
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2.1. Venezuela, Colombia and Peru
Three cases of human melioidosis have been described in Venezuela from 1995 to 2003 [4,6].
In Colombia, after the first report in 1998 [27], a total of 11 further cases have been described up to
2015 (Table 1) [1–6,13,14,19–22,24–29]. Initially, the reports were clustered in the region of Antioquia,
where there is a university referral hospital, although two cases were reported from other regions.
In Peru, despite the initial report of environmental isolation, it was not until 2016 that the first human
case was reported [21].
2.2. Brazil
The first documented cases of melioidosis in Brazil occurred in 2003 in the state of Ceará, located
in the Northeastern region. Four siblings acquired acute infection after recreational exposure at the
town dam and three of them died within a week [7–10]. By 2017, 30 cases had been diagnosed
in Ceará [2,11,15–18,23]. Characterisation of clinical and environmental B. pseudomallei from Ceará
showed that considerable genetic diversity is present [30]. Apart from this, there are only two other
states with confirmed cases in Brazil: a case reported in 2007 in the state of Mato Grosso, located in the
Midwestern region [12] and the other in Alagoas, also located in Northeastern region (Figure 2) [2].
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2.3. Environmental Isolation
Besides the environmental isolation of B. pseudomallei reported in Peru and Brazil in 1977 [25],
it has also been isolated in the Brazilian states of Ceará [31] and Amapá [32], located in the Northern
region. The first attempts at environmental isolation in Brazil were made in 1973 in rice plantations in
rural São Paulo, but these were unsuccessful [33].
2.4. Animal Melioidosis
There have been no reports of melioidosis in animals anywhere in South America.
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measures to enhance surveillance and management of melioidosis in Ceará have been established
gradually, such as the development of a complete protocol in Brazilian Portuguese covering issues
such as: definition of a suspect case, notification and environmental investigations; procedures for
diagnosis and treatment, workflows for the submission of laboratory samples, and recommendations
for prevention. Other activities were developed: professional training materials, dissemination
of information about melioidosis at local, regional and national scientific events, research and
development, the use of new media and educational technology (for example, the establishment
of a web site: https://www.melioidose.com.br), trials of developing prospective surveillance in health
services, and raising laboratory diagnostic capacity. However, it would be fair to say that the success
of these initiatives has been limited. Professional awareness remains restricted to small groups of
physicians in Fortaleza, the state capital of Ceará. In addition, the general population does not know
about the disease, with rare exceptions such as in the locations where cases have been confirmed.
The scarcity and limited capabilities of microbiology laboratories in most regions of Brazil is
also important in this respect. Preliminary studies in Ceará have demonstrated that few laboratories
are able to identify B. pseudomallei. In this state, most cases have occurred in small communities and
the diagnosis was only made when patients were transferred to larger reference centres located in
Fortaleza or the northern and southern regions of the state.
As far as the rest of South America is concerned, there are no policies relating to melioidosis
and no formal surveillance for the disease. Even in Colombia, where the greatest number of cases
outside Brazil have been detected, there are currently no specific or general public policies relating
to melioidosis.Currently, in Colombia the National Institute of Health conducts indirect surveillance
through the surveillance of antimicrobial resistance, but melioidosis is not statutorily notifiable and
is thus likely to be under-recognised. However, a pilot study to identify cases of melioidosis in
Colombia has recently been initiated. This collaborative study involving the US CDC, Tephinet,
the National Institute of Health and some of the larger referral hospitals in Antioquia, will develop an
epidemiological surveillance protocol and attempt to identify new cases of melioidosis, which will
be confirmed using techniques such as MALDI-TOF and molecular methods.Once the collaborative
project is completed, the newly identified cases and a more formal melioidosis surveillance program
for Colombia will be announced. Concern over the emergence of melioidosis recently led to the first
meeting focused on ‘Melioidosis in the Americas’ in Bogota in April 2018, which was attended by
representatives from Brazil, Colombia, Dominican Republic, Ecuador, Haiti, Panama, Paraguay, Peru,
Puerto Rico, Trinidad and Tobago, and the USA. A pamphlet on melioidosis in Spanish was developed,
which could used by public health stakeholders to improve recognition of the disease in Latin America.
It is hoped that this meeting will be the basis for further collaborations and perhaps even a regional
network to share information to improve melioidosis surveillance.
4. Current Challenges and Perspective
The biggest challengesrelating to melioidosis in South America are:
1. To raise professional and government awareness that this disease is present.
2. To alert clinicians to the fact that its early detection is critical if lives are to be saved.
In Ceará, new approaches have been designed such as the inclusion of melioidosis in the
curriculum of professional physicians, and the development of capacity amongst laboratory staff.
The Brazilian health system is organized according to the Sistema Único de Saúde (SUS), geared
to address the priorities for the local population. A recent pilot study involved the provision
of information about melioidosis to community health agents in cities and towns in rural areas.
These agents are part of the Family Health Strategy, a pillar of the development of primary care.
Historically, these professionals have played a major role in reducing the mortality from infectious
diseases in infants, such as diarrhoea, pneumonia, and measles [35]. Considering the environmental,
social and geographic context of melioidosis, it is possible that using this network might help to
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raise the awareness of melioidosis in the wider community. Lessons learned in Brazil might then be
extended to the rest of the continent. In addition, efforts should be made to integrate melioidosis into
the infectious diseases agenda of pan-American meetings and organisations such as the Pan-American
Health Organisation, in order to raise the profile of the disease and to initiate discussions with
national public health organisations, universities and academic communities across the continent.
Consideration should be given to making the disease notifiable in countries where it is predicted to
be present.
An additional problem for South America is the relative under-development of the diagnostic
microbiology sector. This is not something that warrants specific attention as far as melioidosis is
concerned, but as laboratory capacity across the continent improves, it will be important to ensure
that technicians are trained in the isolation and identification of B. pseudomallei. It is hoped that
developments in Brazil and Colombia, and the recent meeting in Bogota, will help to catalyse the
development of an integrated laboratory network among South American countries.
Although melioidosis is a relatively new disease to South America and the numbers of confirmed
cases are as yet small, it is likely that it is being substantially under-diagnosed. It is only by sharing
experiences about organizing and planning surveillance activities in different places, taking into
consideration the individuality of each set of circumstances, that we may begin to understand the size
and extent of the problem. Shared dialogue, discussion and co-ordinated actions in both Portuguese
and Spanish may be the first step to reach the goal. We believe that it is essential that health authorities
(national, state and municipal) should pay attention to this emerging problem. Investment in strategies
already initiated must continue if the lack of knowledge about melioidosis in the continent is to
be addressed.
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